Free tool

Cell therapy stocks

We cover 9 companies grouped under the Cell therapy theme. The median market value in the group is $291.63M. Across the group, the median move over the past trading day is +0.59%. Price change over the past year runs from −48.9% to +17.1% across the middle 80 percent of the group, with a median of −32.3%.

Other lists in this group

Table

9 of 86 companies match these filters.Clear filters

TickerCompanyPrice1M returnYTD return1Y return
MSB.AXMesoblast Limited2.40 AUD+16.26%−13.54%−3.82%
4592.TSanBio Company Limited1,024.00 JPY+10.58%−37.45%−55.90%
005690.KSPharmicell Co., Ltd.10,830.00 KRW+10.85%−24.90%+1.56%
219A.THEARTSEED INC2,365.00 JPY+36.94%+31.02%−32.33%
4894.TCuorips Inc.5,670.00 JPY+37.29%−8.84%−19.00%
4593.THealios K.K.283.00 JPY+25.22%+0.71%−40.92%
7774.TJapan Tissue Engineering Co., Ltd.875.00 JPY+41.82%+49.57%+79.30%
504A.TInnovacell Inc.555.00 JPY+17.34%−47.14%−47.14%
OCC.AXOrthocell Limited0.78 AUD+9.86%−30.36%−35.00%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse